President’s administration sets aside $70 million for new test development. On Monday, the White House announced that it would begin a cross-department initiative to make over-the-counter at-home COVID-19…
Read MoreFood and Drug Administration
White House Announces Plan to Vaccinate Children
28 million children between 5 and 11 years old could be eligible if the vaccine is approved next month. The White House announced on Wednesday that it is…
Read More
EPA Announces New Regulations on Toxic Chemicals
FDA and Defense Department to address PFAS in food and water supplies. The U.S. Environmental Protection Agency announced on Monday that it would be rolling out a new…
Read More
FDA Studies Moderna Shot’s Side Effects in Youth
Approval paused for evaluation of myocarditis in males under 30. The Food and Drug Administration is reportedly delaying approval of Moderna’s COVID-19 authorization for teens to study the…
Read More
FDA Panel Endorses J&J Booster Shot
Advisors unanimously approve. Johnson & Johnson’s vaccine was the only approved COVID-19 vaccine that only technically required a single dose to be effective. After a number of additional…
Read More
FDA Panel Recommends Authorizing Moderna Boosters
Boosters are a priority with the president’s administration. On Thursday, a Food and Drug Administration panel unanimously voted in favor of Moderna’s COVID-19 booster. The committee said boosters…
Read More
Pfizer Seeks FDA Approval for Shots for Children 5 to 11
28 million children could soon be eligible for vaccination. On Thursday, Pfizer formally requested approval from the Food and Drug Administration (FDA) to begin administering COVID-19 vaccines to…
Read More
J&J Seeks FDA Approval for Booster Shots
Claims second shot increases protection 13 percentage points. On Tuesday, Johnson & Johnson requested the Food and Drug Administration (FDA) to approve additional use of its COVID-19 vaccine…
Read More
New Pill “Gamechanger” Against COVID
Cuts hospitalizations and deaths in half. Pharmaceutical company Merck says new data on Molnupiravir shows a reduced risk of hospitalization or death by up to 50 percent in clinical trials. …
Read More
CDC Director Recommends Boosters
The move sidesteps guidance by an FDA panel last week. Centers for Disease Control and Prevention Rochelle Walensky released an endorsement of recommendations by the Advisory Committee on…
Read More